Related references
Note: Only part of the references are listed.Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
Isabelle Sermet-Gaudelus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
The Genomic, Biochemical, and Cellular Responses of the Retina in Inherited Photoreceptor Degenerations and Prospects for the Treatment of These Disorders
Alexa N. Bramall et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 33 (2010)
Light-dependent translocation of arrestin in rod photoreceptors is signaled through a phospholipase C cascade and requires ATP
Wilda Orisme et al.
CELLULAR SIGNALLING (2010)
Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
Richard S. Finkel
JOURNAL OF CHILD NEUROLOGY (2010)
Beneficial Read-Through of a USH1C Nonsense Mutation by Designed Aminoglycoside NB30 in the Retina
Tobias Goldmann et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa
K. Guerin et al.
EXPERIMENTAL EYE RESEARCH (2008)
Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease
Mariya Moosajee et al.
HUMAN MOLECULAR GENETICS (2008)
UMD-USHbases: a comprehensive set of databases to record and analyse pathogenic mutations and unclassified variants in seven Usher syndrome causing genes
David Baux et al.
HUMAN MUTATION (2008)
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
Eitan Kerem et al.
LANCET (2008)
Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases
Mariana Hainrichson et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model
Ming Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Introducing sense into nonsense in treatments of human genetic diseases
Liat Linde et al.
TRENDS IN GENETICS (2008)
SANS (USH1G) expression in developing and mature mammalian retina
Nora Overlack et al.
VISION RESEARCH (2008)
A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells
Tina Maerker et al.
HUMAN MOLECULAR GENETICS (2008)
A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes
Christian Johannes Gloeckner et al.
PROTEOMICS (2007)
In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome
Annie Rebibo-Sabbah et al.
HUMAN GENETICS (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers
Samit Hirawat et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Deafblindness in French Canadians from Quebec: a predominant founder mutation in the USH1C gene provides the first genetic link with the Acadian population
Inga Ebermann et al.
GENOME BIOLOGY (2007)
Cochlear implantation and quality of life in postlingually deaf adults: Long-term follow-up
Godelieve W. J. A. Damen et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2007)
Photoreceptor vitality in organotypic cultures of mature vertebrate retinas validated by light-dependent molecular movements
Boris Reidel et al.
VISION RESEARCH (2006)
Translational readthrough induction of pathogenic nonsense mutations
Richard Kellermayer
EUROPEAN JOURNAL OF MEDICAL GENETICS (2006)
Molecular basis of human Usher syndrome:: Deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease
Jan Reiners et al.
EXPERIMENTAL EYE RESEARCH (2006)
Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2
J Reiners et al.
HUMAN MOLECULAR GENETICS (2005)
Electroporation and RNA interference in the rodent retina in vivo and in vitro
T Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations
M Wilschanski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Differential distribution of harmonin isoforms and their possible role in Usher-1 protein complexes in mammalian photoreceptor cells
J Reiners et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Myosin VIIa, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle
B Boëda et al.
EMBO JOURNAL (2002)
Mutations in the alternatively spliced exons of USH1C cause non-syndromic recessive deafness
XM Ouyang et al.
HUMAN GENETICS (2002)
Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USHIC
ZM Ahmed et al.
HUMAN GENETICS (2002)
A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C
E Verpy et al.
NATURE GENETICS (2000)
Share Paper
